PubMed for id: 387715

Year	Number of Results
2002	1
2005	2
2006	4
2007	18
2008	26
2009	28
2010	32
2011	23
2012	25
2013	26
2014	22
2015	15
2016	12
2017	12
2018	7
2019	7
2020	9
2021	8
2022	4
2023	5
2024	1

1

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.

Hayashida M, Miki A, Nakai S, Matsumiya W, Imai H, Kusuhara S, Honda S, Nakamura M. Hayashida M, et al. Mol Vis. 2020 Jul 4;26:505-509. eCollection 2020. Mol Vis. 2020. PMID: 32774081 Free PMC article.

2

Meta-Analysis of the Pharmacogenetics of ARMS2 A69S Polymorphism and the Response to Advanced Age-Related Macular Degeneration.

Zhang J, Liu Z, Hu S, Qi J. Zhang J, et al. Ophthalmic Res. 2021;64(2):192-204. doi: 10.1159/000508738. Epub 2020 May 19. Ophthalmic Res. 2021. PMID: 32428913 Free article. Review.

3

Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy.

Park UC, Shin JY, Chung H, Yu HG. Park UC, et al. BMC Ophthalmol. 2017 Dec 7;17(1):241. doi: 10.1186/s12886-017-0631-z. BMC Ophthalmol. 2017. PMID: 29212537 Free PMC article.

4

ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration.

Nakai S, Honda S, Matsumiya W, Miki A, Nakamura M. Nakai S, et al. Mol Vis. 2017 Jul 26;23:514-519. eCollection 2017. Mol Vis. 2017. PMID: 28761324 Free PMC article.

5

ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up.

Valverde-Megías A, Veganzones-de-Castro S, Donate-López J, Maestro-de-Las-Casas ML, Megías-Fresno A, García-Feijoo J. Valverde-Megías A, et al. Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2091-2098. doi: 10.1007/s00417-017-3748-0. Epub 2017 Jul 25. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28744656

6

Association of combined cigarette smoking and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: A meta-analysis.

Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, Soheilian M, Nikkhah H. Jabbarpoor Bonyadi MH, et al. Ophthalmic Genet. 2017 Jul-Aug;38(4):308-313. doi: 10.1080/13816810.2016.1237664. Epub 2017 Jan 17. Ophthalmic Genet. 2017. PMID: 28095100 Review.

7

The unconventional secretion of ARMS2.

Kortvely E, Hauck SM, Behler J, Ho N, Ueffing M. Kortvely E, et al. Hum Mol Genet. 2016 Aug 1;25(15):3143-3151. doi: 10.1093/hmg/ddw162. Epub 2016 Jun 6. Hum Mol Genet. 2016. PMID: 27270414

8

Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.

Saksens NT, Lechanteur YT, Verbakel SK, Groenewoud JM, Daha MR, Schick T, Fauser S, Boon CJ, Hoyng CB, den Hollander AI. Saksens NT, et al. PLoS One. 2016 Jun 3;11(6):e0144367. doi: 10.1371/journal.pone.0144367. eCollection 2016. PLoS One. 2016. PMID: 27258093 Free PMC article.

9

Calcium, ARMS2 genotype, and Chlamydia pneumoniae infection in early age-related macular degeneration: a multivariate analysis from the Nagahama study.

Nakata I, Yamashiro K, Kawaguchi T, Nakanishi H, Akagi-Kurashige Y, Miyake M, Tsujikawa A, Yamada R, Matsuda F, Yoshimura N; Nagahama Study Group. Nakata I, et al. Sci Rep. 2015 Mar 20;5:9345. doi: 10.1038/srep09345. Sci Rep. 2015. PMID: 25792034 Free PMC article.

10

Association between variants A69S in ARMS2 gene and response to treatment of exudative AMD: a meta-analysis.

Hu Z, Xie P, Ding Y, Yuan D, Liu Q. Hu Z, et al. Br J Ophthalmol. 2015 May;99(5):593-8. doi: 10.1136/bjophthalmol-2014-305488. Epub 2014 Sep 2. Br J Ophthalmol. 2015. PMID: 25185256 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

242 results

Results by year